MDXG vs. NBIS
MDXG (MiMedx Group, Inc.) and NBIS (Nebius Group N.V.) are both stocks. MDXG operates in Medical Devices (Healthcare), while NBIS operates in Internet Content & Information (Communication Services). Over the past year, MDXG returned -37.21% vs 479.72% for NBIS. At a 0.11 correlation, their price movements are largely independent.
Performance
MDXG vs. NBIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDXG achieves a -44.90% return, which is significantly lower than NBIS's 228.83% return.
MDXG
- 1D
- 1.63%
- 1M
- 3.04%
- YTD
- -44.90%
- 6M
- -46.71%
- 1Y
- -37.21%
- 3Y*
- -16.69%
- 5Y*
- -19.61%
- 10Y*
- -6.83%
NBIS
- 1D
- -2.95%
- 1M
- 28.16%
- YTD
- 228.83%
- 6M
- 205.73%
- 1Y
- 479.72%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MDXG vs. NBIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MDXG MiMedx Group, Inc. | -44.90% | -29.63% | 65.01% |
NBIS Nebius Group N.V. | 228.83% | 202.18% | 46.25% |
Correlation
The correlation between MDXG and NBIS is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2024 | 0.11 |
Fundamentals
MDXG:
$553.70M
NBIS:
$85.04B
MDXG:
$0.21
NBIS:
$3.17
MDXG:
18.14
NBIS:
86.70
MDXG:
0.00
NBIS:
29.79
MDXG:
1.43
NBIS:
82.60
MDXG:
2.28
NBIS:
11.75
MDXG:
$389.42M
NBIS:
$877.90M
MDXG:
$315.59M
NBIS:
$420.60M
MDXG:
$53.81M
NBIS:
-$52.78M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDXG vs. NBIS — Risk / Return Rank
MDXG
NBIS
MDXG vs. NBIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MDXG | NBIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.50 | ||
| Sortino ratioReturn per unit of downside risk | -5.40 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.47 | -0.61 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 10.64 | -11.25 |
| Martin ratioReturn relative to average drawdown | -1.15 | 24.32 | -25.47 |
Loading charts...
Drawdowns
MDXG vs. NBIS - Drawdown Comparison
The maximum MDXG drawdown since its inception was -93.83%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for MDXG and NBIS.
Loading charts...
Drawdown Indicators
| MDXG | NBIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.83% | -58.27% | -35.56% |
Max Drawdown (1Y)Largest decline over 1 year | -61.24% | -45.47% | -15.77% |
Max Drawdown (3Y)Largest decline over 3 years | -68.36% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -83.39% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -93.60% | — | — |
Current DrawdownCurrent decline from peak | -79.23% | -3.99% | -75.24% |
Average DrawdownAverage peak-to-trough decline | -53.56% | -18.69% | -34.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.31% | 19.85% | +12.46% |
Volatility
MDXG vs. NBIS - Volatility Comparison
The current volatility for MiMedx Group, Inc. (MDXG) is 8.42%, while Nebius Group N.V. (NBIS) has a volatility of 27.11%. This indicates that MDXG experiences smaller price fluctuations and is considered to be less risky than NBIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDXG | NBIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.42% | 27.11% | -18.69% |
Volatility (6M)Calculated over the trailing 6-month period | 30.52% | 71.03% | -40.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.89% | 104.65% | -61.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.92% | 109.87% | -47.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.93% | 109.87% | -35.94% |
Dividends
MDXG vs. NBIS - Dividend Comparison
Neither MDXG nor NBIS has paid dividends to shareholders.
Financials
MDXG vs. NBIS - Financials Comparison
This section allows you to compare key financial metrics between MiMedx Group, Inc. and Nebius Group N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MDXG and NBIS have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NBIS has higher volatility (27.11%) compared to MDXG (8.42%). In terms of maximum drawdown, MDXG dropped -93.83% vs NBIS's -58.27%.
NBIS currently has the higher Sharpe Ratio (4.62 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDXG and NBIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer